Core Insights - Corning Incorporated (NYSE: GLW) is scheduled to report its earnings on July 29, 2025, with historical data indicating a tendency for negative one-day returns post-earnings announcements, occurring in 60% of cases [2][3] Financial Performance - Analysts project earnings of $0.57 per share on revenues of $3.84 billion for the upcoming quarter, showing an improvement from the previous year's earnings of $0.47 per share on revenues of $3.60 billion [3] - Corning has an estimated market capitalization of around $48 billion, with $14 billion in revenue generated over the past twelve months, operational profits of $1.3 billion, and a net income of $454 million [4] Historical Earnings Reaction - Over the past five years, Corning has recorded 20 earnings data points, with 8 positive and 12 negative one-day returns, resulting in positive returns approximately 40% of the time [6] - The median of the 8 positive returns is 3.9%, while the median of the 12 negative returns is -3.1% [6] Post-Earnings Return Analysis - The correlation between short-term (1D) and medium-term (5D, 21D) returns can guide trading strategies, with a focus on pairs that show the strongest correlation [7] - Historical data indicates that the correlation between 1D and 5D returns can be utilized for positioning trades following earnings announcements [7] Competitor Influence - The performance of competitors can impact Corning's post-earnings stock response, with pricing effects potentially starting before the earnings announcement [8]

Core Viewpoint - Sotera Health Company will release its financial results for the second quarter ended June 30, 2025, on August 8, 2025, before market opening, followed by a conference call to discuss the results and operating highlights [1]. Company Overview - Sotera Health is a leading global provider of end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, operating through three businesses: Sterigenics, Nordion, and Nelson Labs [3]. - The company's mission is to safeguard global health [3]. Conference Call Details - The conference call will take place at 9:00 a.m. Eastern Daylight Time on August 8, 2025, with participation options provided for both U.S. and international callers [2]. - A live webcast of the conference call will be available on the company's website, along with accompanying materials, and a replay will be accessible later that day [2].

Core Insights - QuickLogic Corporation has launched Aurora PRO, an advanced FPGA design tool that integrates Synopsys Synplify® for enhanced eFPGA designs [1][3][6] Group 1: Product Features - Aurora PRO offers significant performance improvements, achieving up to 50% better resource utilization and over 96% LUT utilization in customer designs [3] - The integration with Synopsys Synplify® results in average frequency increases of up to 10%, enhancing overall system performance [3][4] - The tool is optimized for QuickLogic's eFPGA architecture, specifically targeting embedded carry chains, BRAM, and DSP blocks to reduce critical path delays [4] Group 2: User Experience - Aurora PRO features a redesigned user interface that integrates Synopsys Synplify® synthesis within the Aurora GUI, facilitating easier management of area vs. timing trade-offs [5] - The intuitive environment accelerates experimentation and enables faster iterations for optimal design parameters [5] Group 3: Strategic Importance - The introduction of Aurora PRO is a significant milestone for QuickLogic's eFPGA design capabilities, aimed at accelerating design workflows and enhancing area and timing optimizations [6] - This advancement is expected to empower engineers to maximize performance and efficiency, ultimately reducing time-to-market for innovative products [6]

JOYY Inc. (NASDAQ: JOYY ) is one of those tech stocks that are in plain sight. I believe that the company is currently undergoing a radical change. It may appear to be just another live-streaming company that isSaba Sadiq is a psychologist who has always been interested in finance, and is passionate about uncovering insights in the market and assisting others in making sound financial choices. Being heavily invested in data-driven approach, Saba aims to guide investors through the uncertainties of the finan ...

Core Insights - HealthLynked Corp. has launched a newly designed Enterprise Healthcare Solutions Website and enhanced its consumer-facing provider directory, positioning itself as a key technology partner in the healthcare sector [1][2]. Group 1: New Website Launch - The new website serves as a dedicated platform for HealthLynked's commercial partners, showcasing tailored solutions for various stakeholders in the healthcare ecosystem [2]. - Dr. Michael Dent, CEO of HealthLynked, emphasized that the website reflects the company's expanding role and commitment to scalable solutions that improve healthcare outcomes and reduce costs [2][4]. Group 2: Enhanced Provider Directory - Major upgrades to the national provider directory have been implemented to enhance user experience, providing patients with more flexibility and transparency in selecting providers [3][6]. - The improvements aim to empower patients with smarter tools to manage their healthcare needs effectively [3][4]. Group 3: Strategic Vision and Commitment - The combination of the new website and upgraded provider directory demonstrates HealthLynked's commitment to innovation and strengthening strategic relationships within the healthcare landscape [4]. - The company continues to invest in technology that supports personalized patient care and enterprise-scale efficiency [4][5]. Group 4: Company Overview - HealthLynked Corp. is transforming healthcare through a cloud-based platform that connects patients and providers, offering secure medical record management, AI-driven insights, and a robust provider directory [5]. - The company provides various services tailored to insurance carriers, pharmaceutical companies, advertising firms, ACOs, healthcare networks, and large employers, focusing on improving access, cost savings, and coordinated care [5].

The Q2 earnings season is offering a positive picture, with an above-average number of companies surpassing consensus estimates.More significantly, a stabilizing macroeconomic environment and encouraging management commentary are helping to reverse the prior trend of downward revisions. As a result, the earnings estimates for the second half of the year are beginning to rise once again.For the 117 S&P 500 companies that have already reported Q2 results, total earnings are up 8.3% from the same period last y ...

CINCINNATI, July 28, 2025 /PRNewswire/ -- The E.W. Scripps Company (NASDAQ: SSP) has launched an offering of $650 million of new senior secured second-lien notes. The notes are expected to mature in 2030.The private offering is subject to market conditions and other factors and is exempt from the registration requirements of the Securities Act of 1933, as amended. The notes will be guaranteed by certain of the company's existing and future subsidiaries and will be secured on a second-lien basis by substanti ...

Zefiro Lands its First-Ever Methane Monitoring Contract as Part of the EPA's Methane Emissions Reduction Program (MERP)This program is federally funded under the Inflation Reduction Act ("IRA") which specifically provides USD $850 million in grants to reduce, monitor, measure, and quantify methane emissions from the oil and gas sector. The contract recently awarded to Zefiro by the West Virginia Department of Environmental Protection was expanded beyond its initial scope, and will earn Zefiro ...

Adaptimmune Announces Entry into Definitive Agreement for Sale of TECELRA, lete-cel, afami-cel and uza-cel Cell Therapies to US WorldMedsJuly 28, 2025 7:30 AM EDT | Source: Adaptimmune Therapeutics PLCTecelra will continue to be available to patients without interruption US WorldMeds plans to bring lete-cel to market and will continue development of uza-cel in collaboration with GalapagosPurchase price is $55m in cash to be paid upon consummation of the sale with up to $30m in potential future ...

On July 31st, the much anticipated Q2 2025 quarterly report will be released by Medical Properties Trust (NYSE: MPW ), so the question is: why bother to write an article a few days before? Well, because I believe that what I'm aboutI'm Luuk Wierenga, an economics teacher from the Netherlands with a strong passion for income investing. My investment journey began during the COVID-19 pandemic, and since then, I've specialized in identifying Real Estate Investment Trusts (REITs) that are temporarily out-of-fav ...